Butabarbital

  • TRADE NAMES: Butalan; Buticaps; Butisol (MedPointe); Day-Barb
  • INDICATIONS: Sedation
  • CLASS: Barbiturate
  • HALF-LIFE: 40–140 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Alcohol, Antihistamines, Ardeparin, Argatroban, Brompheniramine, Buclizine, Chlorpheniramine, Dalteparin, Danaparoid, Dicumarol, Enoxaparin, Ethanolamine, Heparin, Imatinib, Tinzaparin, Warfarin

PREGNANCY CATEGORY: D

Our database has 15 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
CARDIOVASCULAR.
NEUROMUSCULAR/SKELETAL.


Page last updated 08/02/2021

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top